Combining pharmacotherapy with cognitive behavioral therapy: Traditional and new approaches
The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
Given the ever‐increasing sources of trauma both nationally and globally, it is imperative to develop new and better treatments for anxiety disorders such as posttraumatic stress disorder (PTSD). This review is a collection of presentations that seek to do just that, either by using pharmacotherapy to try to prevent or erase the formation of traumatic fear memories, or to enhance exposure‐based cognitive–behavioral therapy using pharmacological agents that have been effective in enhanced extinction of fear in rodents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ressler, K. J., Rothbaum, B. O., Tannenbaum, L., Anderson, P., Graap, K., Zimand, E., Hodges, L., & Davis, M. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1136 · Cited by 1,063
Self-citationFoa, E. B., Liebowitz, M. R., Kozak, M. J., Davies, S., Campeas, R., Franklin, M. E., Huppert, J. D., Kjernisted, K., Rowan, V., Schmidt, A. B., et al. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.1.151 · Cited by 1,048
Pilot study of secondary prevention of posttraumatic stress disorder with propranolol
Pitman, R. K., Sanders, K. M., Zusman, R. M., Healy, A. R., Cheema, F., Lasko, N. B., Cahill, L., & Orr, S. P. (2002) · Biological Psychiatry · doi:10.1016/s0006-3223(01)01279-3 · Cited by 964
Barlow, D. H., Gorman, J. M., Shear, M. K., & Woods, S. W. (2000) · JAMA · doi:10.1001/jama.283.19.2529 · Cited by 953
Walker, D. L., Ressler, K. J., Lu, K.-T., & Davis, M. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-06-02343.2002 · Cited by 815
Self-citationExtinction of fear-potentiated startle: blockade by infusion of an NMDA antagonist into the amygdala
Falls, W., Miserendino, M., & Davis, M. (1992) · The Journal of Neuroscience · doi:10.1523/jneurosci.12-03-00854.1992 · Cited by 673
Self-citationDębiec, J., & Ledoux, J. E. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.08.018 · Cited by 602
Augmentation of Exposure Therapy With D-Cycloserine for Social Anxiety Disorder
Hofmann, S. G., Meuret, A. E., Smits, J. A. J., Simon, N. M., Pollack, M. H., Eisenmenger, K., Shiekh, M., & Otto, M. W. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.3.298 · Cited by 560
Self-citationA meta-analysis of treatment outcome for panic disorder
Gould, R. A., Ott, M. W., & Pollack, M. H. (1995) · Clinical Psychology Review · doi:10.1016/0272-7358(95)00048-8 · Cited by 520
Marks, I. M., Swinson, R. P., Başoǧlu, M., Kuch, K., Noshirvani, H., O'Sullivan, G., Lelliott, P. T., Kirby, M., McNamee, G., Sengun, S., et al. (1993) · British Journal of Psychiatry · doi:10.1192/bjp.162.6.776 · Cited by 478
Cited by
Neural Mechanisms of Extinction Learning and Retrieval
Quirk, G. J., & Mueller, D. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301555 · Cited by 1,645
Mithoefer, M. C., Wagner, M. T., Mithoefer, A. T., Jerome, L., & Doblin, R. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378371 · Cited by 674
“Data about combined psychotherapy and pharmacotherapy are limited to a few small studies with mixed results (Foa et al., 2009; Davis et al., 2006; Rothbaum et al., 2006).”
BackgroundWessa, M., & Flor, H. (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07030525 · Cited by 323
Memory Retrieval and the Passage of Time: From Reconsolidation and Strengthening to Extinction
Inda, M. C., Muravieva, E. V., & Alberini, C. M. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.4736-10.2011 · Cited by 261
Feelings Into Words: Contributions of Language to Exposure Therapy
Kircanski, K., Lieberman, M. D., & Craske, M. G. (2012) · Psychological Science · doi:10.1177/0956797612443830 · Cited by 249
Combined pharmacotherapy and psychological therapies for post traumatic stress disorder (PTSD)
Hetrick, S. E., Purcell, R., Garner, B., & Parslow, R. (2010) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007316.pub2 · Cited by 212
D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder
Storch, E. A., Merlo, L. J., Bengtson, M., Murphy, T. K., Lewis, M. H., Yang, M. C., Jacob, M. L., Larson, M., Hirsh, A., Fernandez, M., et al. (2007) · International Clinical Psychopharmacology · doi:10.1097/yic.0b013e32819f8480 · Cited by 200
“An alternative approach involves targeting neural mechanisms involved in the acquisition and retention of fear learning (Davis, 2002; Davis et al., 2006).”
BackgroundChildhood trauma, posttraumatic stress disorder, and alcohol dependence
Brady, K. (2012) · Alcohol Research: Current Reviews · doi:10.35946/arcr.v34.4.05 · Cited by 164
Modi, M. E., & Young, L. J. (2011) · Biological Psychiatry · doi:10.1016/j.biopsych.2011.01.026 · Cited by 47
“The crux of the successful use of DCS in the treatment of these disorders is the combination of pharmacotherapy with behavioral therapies (53,54,56).”
BackgroundMemory extinction entails the inhibition of the transcription factor NF-κB
Merlo, E., & Romano, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0003687 · Cited by 47
“Taking into account that pharmacological interventions to enhance extinction have been proposed as potential approaches to the treatment of maladaptive memory disorders [45–48], the elucidation of novel molecular mechanisms underlying extinction could help to identify novel molecular candidates for pharmacological int…”
Background
Metadata
- Authors
- Davis, M., Barad, M., Otto, M., & Southwick, S.
- Venue
- Journal of Traumatic Stress
- Publisher
- Wiley
- Published
- 2006-10
- Volume
- 19
- Issue
- 5
- Pages
- 571-581
- ISSN
- 0894-9867 (ISSN-L)
- 1573-6598
- OpenAlex
- W1977983425
- Cited by
- 55
- References
- 21
- FWCI
- 5.14
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.